{"id":617944,"date":"2022-09-22T18:24:02","date_gmt":"2022-09-22T18:24:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=617944"},"modified":"2022-09-22T18:24:02","modified_gmt":"2022-09-22T18:24:02","slug":"sinus-dilation-devices-market-worth-38-billion-by-2027-exclusive-report-by-marketsandmarkets","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/sinus-dilation-devices-market-worth-38-billion-by-2027-exclusive-report-by-marketsandmarkets_617944.html","title":{"rendered":"Sinus Dilation Devices Market worth $3.8 billion by 2027 &#8211; Exclusive Report by MarketsandMarkets\u2122"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1663836879.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Sinus Dilation Devices Market worth $3.8 billion by 2027 - Exclusive Report by MarketsandMarkets&trade;\" src=\"https:\/\/www.abnewswire.com\/uploads\/1663836879.jpeg\" alt=\"Sinus Dilation Devices Market worth $3.8 billion by 2027 - Exclusive Report by MarketsandMarkets&trade;\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Some of the players operating in North American market are Acclarent, inc. (a subsidiary of Johnson &#038; Johnson) (US), Entellus Medical Inc. (A Subsidiary of Stryker) (US), Intersect ENT, Inc. (US), SinuSys Corporation (US), Optim LLC (US), Sklar Surgical Instruments (US), Dalent Medical (US), Summit Medical LLC. (US), and Cook Medical (US)<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">In 2021, Intersect ENT (US) announced the launch of the new Straight Delivery System packaged with the PROPEL Mini Sinus Implant.<\/div>\n<p style=\"text-align: justify;\"><strong><a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/sinus-dilation-device-market-64349810.html?utm_source=abnewswire&amp;utm_medium=referral\" target=\"_blank\">Sinus Dilation Devices Market<\/a>&nbsp;is projected to grow from&nbsp;USD 2.8 billion&nbsp;in 2022 to&nbsp;USD 3.8 billion&nbsp;by 2027, at a CAGR of 6.6% from 2022 to 2027, according to a new report by MarketsandMarkets&trade;.<\/strong>&nbsp;The growth of this market is majorly driven by Increasing availability of reimbursements, Increasing cases of chronic sinusitis. However, Availability of non-surgical treatments for chronic sinusitis and lack of skilled ENT surgeons are some of the restraints for which may hinder the growth of this market.<\/p>\n<p style=\"text-align: justify;\"><strong>Download PDF Brochure:&nbsp;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=64349810&amp;utm_source=abnewswire&amp;utm_medium=referral\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=64349810<\/a><\/p>\n<p style=\"text-align: justify;\"><em>Browse in-depth TOC on<\/em><strong>&nbsp;&#8220;Sinus Dilation Devices Market&#8221;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>119 &ndash; Tables<br \/> 42 &ndash; Figures<br \/> 171 &ndash; Pages<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Sinuscope in the endoscope product segment to witness the highest shares during the forecast period.&#8221;<\/strong><\/p>\n<p style=\"text-align: justify;\">Based on the product, the sinus dilation devices market is classified into Balloon sinus dilation devices, Endoscopes (Sinuscopes, Rhinoscopes), Sinus stents\/implants, and Handheld instruments. The sinuscope segment is expected to dominate because of its wider application which provides clear images of the inspection area necessary for diagnostic, therapeutic, and surgical sinus, and nasal procedures likewise Several players are focusing on introducing new products in the market to strengthen their product offerings. These are the key factors driving the growth of the Sinuscopes in the market.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Pages:&nbsp;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=64349810&amp;utm_source=abnewswire&amp;utm_medium=referral\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=64349810<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>US dominates the North American sinus dilation devices market<\/strong><\/p>\n<p style=\"text-align: justify;\">Based on the&nbsp;North America&nbsp;region, the sinus dilation devices market is divided into US and&nbsp;Canada. US is expected to dominate the sinus dilation devices market. The increasing prevalence of sinusitis and the subsequent increase in the number of surgical procedures performed, favourable reimbursement scenarios for sinus dilation procedures, and the availability of technologically advanced sinus dilation devices, are the key factor driving market growth in the US.<\/p>\n<p style=\"text-align: justify;\">The major players in the sinus dilation devices market are Acclarent, inc. (a subsidiary of Johnson &amp; Johnson) (US), Olympus Corporation (Japan), Entellus Medical Inc. (A Subsidiary of Stryker) (US), Medtronic Plc. (Ireland), Smith &amp; Nephew plc (UK), Intersect ENT, Inc. (US), SinuSys Corporation (US), InnAccel Pvt. Ltd (India), MERIL LIFE SCIENCES PVT Ltd. (India), Optim LLC (US).<\/p>\n<p style=\"text-align: justify;\"><strong>Get 10% Free Customization on this Report:&nbsp;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=64349810&amp;utm_source=abnewswire&amp;utm_medium=referral\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=64349810<\/a><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_17712.html\" rel=\"nofollow\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Aashish Mehra<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=sinus-dilation-devices-market-worth-38-billion-by-2027-exclusive-report-by-marketsandmarkets\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>630 Dundee Road  Suite 430<br \/><strong>City:<\/strong> Northbrook<br \/><strong>State:<\/strong> IL 60062<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/sinus-dilation-device-market-64349810.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/sinus-dilation-device-market-64349810.html<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/sinus-dilation-device-market-64349810.html\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=sinus-dilation-devices-market-worth-38-billion-by-2027-exclusive-report-by-marketsandmarkets\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Some of the players operating in North American market are Acclarent, inc. (a subsidiary of Johnson &#038; Johnson) (US), Entellus Medical Inc. (A Subsidiary of Stryker) (US), Intersect ENT, Inc. (US), SinuSys Corporation (US), Optim LLC (US), Sklar Surgical Instruments &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/sinus-dilation-devices-market-worth-38-billion-by-2027-exclusive-report-by-marketsandmarkets_617944.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-617944","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/617944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=617944"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/617944\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=617944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=617944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=617944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}